SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-23-066386
Filing Date
2023-11-28
Accepted
2023-11-28 16:00:04
Documents
1
Period of Report
2023-02-20

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 7234
  Complete submission text file 0000950170-23-066386.txt   8544
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 101 HARTWELL AVE. LEXINGTON MA 02421
Business Address
Giffin Brett A. (Reporting) CIK: 0001892921 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36571 | Film No.: 231446259